EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview

Komal Diliprao Dhule iD, Tanaji Dilip Nandgude iD

Advanced Pharmaceutical Bulletin · 01.11.2023 · 13 (4) · 663-677

DOI: 10.34172/apb.2023.075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 29.04.2023. Verfasst von Komal Diliprao Dhule und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dr. D. Y. Patil Institute of Pharmaceutical Science and Research, Pimpri, Pune 411018, Department of Pharmaceutics, Pune, Maharashtra, India. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The overall purpose of rheumatoid arthritis (RA) treatment is to give symptomatic alleviation; there is no recognized cure for RA. Frequent use of potent drugs like non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs), lead to various adverse effects and patient compliance suffers. On the other hand, there are many drawbacks associated with traditional methods, such as high first pass, high clearance rate, and low bioavailability. Drug administration through the skin can be a promising alternative to cope with these drawbacks, increasing patient compliance and providing site-specific action. The stratum corneum, the uppermost non-viable epidermal layer, is one of the primary limiting barriers to skin penetration. Various nanocarrier technologies come into play as drug vehicles to help overcome these barriers. The nanocarrier systems are biocompatible, stable, and have a lower cytotoxic impact. The review discusses several lipid-based nanocarrier systems for anti-rheumatic medicines for topical administration it also discusses in-vivo animal models for RA and provides information on patents granted.

Schlagwörter

Stichwörter der Autor:innen

In vivo animal modelsLipid nanocarriersPatentsRheumatoid arthritis

Autor:innen und Institutionen

  • Dr. D. Y. Patil Institute of Pharmaceutical Science and Research, Pimpri, Pune 411018, Department of Pharmaceutics, Pune, Maharashtra, India.

ORCID-Profile: Komal Diliprao Dhule, Tanaji Dilip Nandgude

Zitieren

APA

Dhule, K. D., & Nandgude, T. D. (2023). Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview. Advanced Pharmaceutical Bulletin, 13(4), 663-677. https://doi.org/10.34172/apb.2023.075

Vancouver

Dhule KD, Nandgude TD. Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview. Advanced Pharmaceutical Bulletin. 2023;13(4):663-677. doi:10.34172/apb.2023.075

BibTeX
@article{Dhule2023,
  author = {Dhule, Komal Diliprao and Nandgude, Tanaji Dilip},
  title = {Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview},
  journal = {Advanced Pharmaceutical Bulletin},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {663--677},
  doi = {10.34172/apb.2023.075}
}
Kostenlos starten →